Fig. 3From: The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney diseaseThe correlation between baseline ECW/TBW and the change in ECW. In the furosemide (a) and tolvaptan (c) groups, the ECW/TBW level was not significantly correlated, while in the Dapagliflozin group (b), it was negatively and significantly correlated. ECW extracellular water, TBW total body waterBack to article page